65 results
8-K
EX-1.1
NRIX
Nurix Therapeutics Inc
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
incentive plans described in, the Registration Statement, the Pricing Disclosure Package and the Prospectus), short-term debt or long-term debt … as an “incentive stock option” under Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), so qualifies, (ii) each grant
424B5
NRIX
Nurix Therapeutics Inc
12 Apr 24
Prospectus supplement for primary offering
5:10pm
compensation plans, consisting of (i) 705,607 shares of common stock reserved for future issuance under our 2020 Equity Incentive Plan (2020 Plan … that may be granted under our equity incentive plans, and when we otherwise issue additional shares of our common stock. Furthermore, if any of our
424B5
NRIX
Nurix Therapeutics Inc
11 Apr 24
Prospectus supplement for primary offering
4:06pm
plans, consisting of (i) 705,607 shares of common stock reserved for future issuance under our 2020 Equity Incentive Plan (2020 Plan), as of February 29 … equity incentive plans, and when we otherwise issue additional shares of our common stock. Furthermore, if any of our outstanding pre-funded warrants
S-8
kycwu6geaej5569x6vo5
15 Feb 24
Registration of securities for employees
4:51pm
S-8
EX-5.1
p3bw8p1 s2co
15 Feb 24
Registration of securities for employees
4:51pm
S-8
yiza1gg
15 Feb 24
Registration of securities for employees
4:51pm
8-K
gb69 swidmzfayv0bfg
14 Sep 22
Nurix Therapeutics Appoints Leading Industry Strategist Edward C. Saltzman to its Board of Directors
4:01pm
8-K
EX-10.1
f08bxofoeear8lz64j8
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
424B5
mcs8o8axf6xy
8 Jul 22
Prospectus supplement for primary offering
4:10pm
424B5
1fol32b0xjj2k6j18
8 Jul 22
Prospectus supplement for primary offering
4:09pm